{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:05:33Z","timestamp":1793862333663,"version":"4.6.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,4,6]],"date-time":"2006-04-06T00:00:00Z","timestamp":1144281600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1186\/1750-1172-1-10","type":"journal-article","created":{"date-parts":[[2006,4,20]],"date-time":"2006-04-20T14:28:02Z","timestamp":1145543282000},"source":"Crossref","is-referenced-by-count":238,"title":["Glanzmann thrombasthenia"],"prefix":"10.1186","volume":"1","author":[{"given":"Alan T","family":"Nurden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,4,6]]},"reference":[{"key":"10_CR1","first-page":"113","volume":"88","author":"E Glanzmann","year":"1918","unstructured":"Glanzmann E: Hereditare hamorrhagische thrombasthenie. Ein Beitrag zur Pathologie der Blutplattchen. J Kinderkranken. 1918, 88: 113-","journal-title":"J Kinderkranken"},{"key":"10_CR2","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood.V11.11.965.965","volume":"11","author":"H Braunsteiner","year":"1956","unstructured":"Braunsteiner H, Pakesch F: Thrombocytoasthenia and thrombocytopathia. Old names and new diseases. Blood. 1956, 11: 965-976.","journal-title":"Blood"},{"key":"10_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/0002-9343(66)90003-9","volume":"44","author":"JP Caen","year":"1966","unstructured":"Caen JP, Castaldi PA, Lecrec JC, Inceman S, Larrieu MJ, Probst M, Bernard J: Glanzmann's thrombasthenia. I. Congenital bleeding disorders with long bleeding time and normal platelet count. Am J Med. 1966, 44: 4-10.1016\/0002-9343(66)90003-9.","journal-title":"Am J Med"},{"key":"10_CR4","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood.V75.7.1383.1383","volume":"75","author":"JN George","year":"1990","unstructured":"George JN, Caen J-P, Nurden AT: Glanzmann's thrombasthenia: The spectrum of clinical disease. Blood. 1990, 75: 1383-1395.","journal-title":"Blood"},{"key":"10_CR5","first-page":"176","volume":"62","author":"Y Chen","year":"1989","unstructured":"Chen Y, Wu QY, Wang Z, et al: Abnormalities of platelet membrane glycoproteins in acute nonlymphoblastic leukemia [abstract]. Thromb Haemost. 1989, 62: 176-","journal-title":"Thromb Haemost"},{"key":"10_CR6","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/blood.V90.10.3951","volume":"90","author":"CC Wilhide","year":"1997","unstructured":"Wilhide CC, Jin Y, Guo Q, Li L, Li SX, Rubin E, Bray PF: The human integrin \u03b23 gene is 63 kb and contains a 5'-UTR sequence regulating expression. Blood. 1997, 90: 3951-3961.","journal-title":"Blood"},{"key":"10_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1365-2141.2004.05173.x","volume":"127","author":"E Tholouli","year":"2004","unstructured":"Tholouli E, Hay CRM, O'Gorman P, Makris M: Acquired Glanzmann's thrombasthenia without thrombocytopenia: a severe acquired autoimmune bleeding disorder. Br J Haematol. 2004, 127: 209-213. 10.1111\/j.1365-2141.2004.05173.x.","journal-title":"Br J Haematol"},{"key":"10_CR8","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/(SICI)1096-8652(199802)57:2<164::AID-AJH13>3.0.CO;2-C","volume":"157","author":"L Macchi","year":"1998","unstructured":"Macchi L, Nurden P, Marit G, Bihour C, Clofent-Sanchez G, Combrie R, Nurden AT: Autoimmune thrombocytopenic purpura (AITP) and acquired thrombasthenia due to autoantibodies to GP IIb-IIIa in a patient with an unusual platelet membrane glycoprotein composition. Am J Hematol. 1998, 157: 164-175. 10.1002\/(SICI)1096-8652(199802)57:2<164::AID-AJH13>3.0.CO;2-C.","journal-title":"Am J Hematol"},{"key":"10_CR9","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1182\/blood.V101.3.929","volume":"101","author":"D Patel","year":"2003","unstructured":"Patel D, V\u00e4\u00e4n\u00e4nen H, Jirouskova M, Hoffmann T, Bodian C, Coller BS: Dynamics of GPIIb\/IIIa-mediated platelet-platelet interactions in platelet adhesion\/thrombus formation on collagen in vitro as revealed by videomicroscopy. Blood. 2003, 101: 929-936. 10.1182\/blood.V101.3.929.","journal-title":"Blood"},{"key":"10_CR10","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/255720a0","volume":"255","author":"AT Nurden","year":"1975","unstructured":"Nurden AT, Caen JP: Specific roles for surface membrane glycoproteins in platelet function. Nature. 1975, 255: 720-722. 10.1038\/255720a0.","journal-title":"Nature"},{"key":"10_CR11","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1182\/blood.V58.2.268.268","volume":"58","author":"TJ Kunicki","year":"1981","unstructured":"Kunicki TJ, Pidard D, Rosa JP, Nurden AT: The formation of Ca2+-dependent complexes of platelet membrane glycoproteins IIb and IIIa in solution as determined by crossed immunoelectrophoresis. Blood. 1981, 58: 268-278.","journal-title":"Blood"},{"key":"10_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0092-8674(92)90115-S","volume":"69","author":"RO Hynes","year":"1992","unstructured":"Hynes RO: Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992, 69: 11-25. 10.1016\/0092-8674(92)90115-S.","journal-title":"Cell"},{"key":"10_CR13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1182\/blood.V77.1.75.75","volume":"77","author":"BS Coller","year":"1991","unstructured":"Coller BS, Cheresh DA, Asch E, Seligsohn U: Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel. Blood. 1991, 77: 75-83.","journal-title":"Blood"},{"key":"10_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature02976","volume":"432","author":"T Xiao","year":"2004","unstructured":"Xiao T, Takagi J, Coller BS, Wang J-H, Springer TA: Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature. 2004, 432: 59-67. 10.1038\/nature02976.","journal-title":"Nature"},{"key":"10_CR15","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0092-8674(00)81607-4","volume":"94","author":"B Savage","year":"1998","unstructured":"Savage B, Almus-Jacobs F, Ruggeri ZM: Specific synergy of multiple substrate-receptor interactions in platelet-thrombus formation under flow. Cell. 1998, 94: 657-666. 10.1016\/S0092-8674(00)81607-4.","journal-title":"Cell"},{"key":"10_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1172\/JCI9896","volume":"106","author":"H Ni","year":"2000","unstructured":"Ni H, Denis CV, Subbarao S, Degen JL, Sato TN, Hynes RO, Wagner DD: Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest. 2000, 106: 385-392.","journal-title":"J Clin Invest"},{"key":"10_CR17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nm0302-247","volume":"8","author":"P Andre","year":"2002","unstructured":"Andre P, Prasad KS, Denis CV, He M, Papalia JM, Hynes RO, Phillips DR, Wagner DD: CD40L stabilizes arterial thrombi by a \u03b23 integrin-dependent mechanism. Nature Med. 2002, 8: 247-252. 10.1038\/nm0302-247.","journal-title":"Nature Med"},{"key":"10_CR18","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1046\/j.1365-2141.2002.03966.x","volume":"119","author":"P Hainaud","year":"2002","unstructured":"Hainaud P, Brouland JP, Andre P, Simoneau G, Bal Dit Sollier C, Drouet L, Caen J, Bellucci S: Dissociation between fibrinogen and fibrin interaction with platelets in patients with different subtypes of Glanzmann's thrombasthenia: studies in an ex vivo perfusion chamber model. Br J Haematol. 2002, 119: 998-1004. 10.1046\/j.1365-2141.2002.03966.x.","journal-title":"Br J Haematol"},{"key":"10_CR19","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1182\/blood-2002-09-2761","volume":"101","author":"T Lisman","year":"2003","unstructured":"Lisman T, Moschatsis S, Adelmeijer J, Nieuwenhuis HK, De Groot PG: Recombinant factor VIIa enhances deposition of platelets with congenital or acquired \u03b1IIb\u03b23 deficiency to endothelial cell matrix and collagen under flow via tissue factor-independent thrombin generation. Blood. 2003, 101: 1864-1870. 10.1182\/blood-2002-09-2761.","journal-title":"Blood"},{"key":"10_CR20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/09537109876951","volume":"9","author":"DL French","year":"1998","unstructured":"French DL: The molecular genetics of Glanzmann's thrombasthenia. Platelets. 1998, 9: 5-20. 10.1080\/09537109876951.","journal-title":"Platelets"},{"key":"10_CR21","doi-asserted-by":"publisher","first-page":"4808","DOI":"10.1182\/blood-2002-08-2452","volume":"101","author":"N Rosenberg","year":"2003","unstructured":"Rosenberg N, Yatuv R, Sobolev V, Peretz H, Zivelin A, Seligsohn U: Major mutations in calf-1 and calf-2 domains of glycoprotein IIb in patients with Glanzmann thrombasthenia enable GPIIb\/IIIa complex formation, but impair its transport from the endoplasmic reticulum to the Golgi apparatus. Blood. 2003, 101: 4808-4815. 10.1182\/blood-2002-08-2452.","journal-title":"Blood"},{"key":"10_CR22","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1073\/pnas.88.8.3160","volume":"88","author":"PJ Newman","year":"1991","unstructured":"Newman PJ, Seligsohn U, Lyman S, Coller BS: The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel. Proc Natl Acad Sci USA. 1991, 88: 3160-3164.","journal-title":"Proc Natl Acad Sci USA"},{"key":"10_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1073\/pnas.94.1.65","volume":"94","author":"TA Springer","year":"1997","unstructured":"Springer TA: Folding of the N-terminal, ligand-binding region of integrin \u03b1-subunits into a \u03b2 \u2013 propeller domain. Proc Natl Acad Sci USA. 1997, 94: 65-72. 10.1073\/pnas.94.1.65.","journal-title":"Proc Natl Acad Sci USA"},{"key":"10_CR24","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1016\/S0021-9258(17)41800-X","volume":"269","author":"DA Wilcox","year":"1994","unstructured":"Wilcox DA, Wauthier JL, Pidard D, Newman PJ: A single amino acid substitution flanking the fourth calcium binding domain of \u03b1IIb prevents maturation of the \u03b1IIb\u03b23 complex. J Biol Chem. 1994, 269: 4450-4457.","journal-title":"J Biol Chem"},{"key":"10_CR25","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1182\/blood-2002-07-2266","volume":"101","author":"WB Mitchell","year":"2003","unstructured":"Mitchell WB, Li JH, Singh F, Michelson AD, Bussel J, Coller BS, French DL: Two novel mutations in the \u03b1IIb calcium-binding domains identify hydrophobic regions essential for \u03b1IIb\u03b23 biogenesis. Blood. 2003, 101: 2268-2276. 10.1182\/blood-2002-07-2266.","journal-title":"Blood"},{"key":"10_CR26","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1055\/s-0037-1613271","volume":"88","author":"S Milet-Marsal","year":"2002","unstructured":"Milet-Marsal S, Breillat C, Peyruchaud O, Nurden P, Combrie R, Nurden AT, Bourre F: Analysis of the amino acid requirement for a normal \u03b1IIb\u03b23 maturation at \u03b1IIbGlu324 commonly mutated in Glanzmann thrombasthenia. Thromb Haemost. 2002, 88: 655-662.","journal-title":"Thromb Haemost"},{"key":"10_CR27","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1046\/j.1538-7836.2004.00711.x","volume":"2","author":"AT Nurden","year":"2004","unstructured":"Nurden AT, Breillat C, Jacquelin B, Combrie R, Freedman J, Blanchette VS, Schmugge M, Rand ML: Triple heterozygosity in the integrin \u03b1IIb subunit in a patient with Glanzmann thrombasthenia. J Thromb Haemost. 2004, 2: 813-819. 10.1046\/j.1538-7836.2004.00711.x.","journal-title":"J Thromb Haemost"},{"key":"10_CR28","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1182\/blood.V99.3.931","volume":"99","author":"S Tadokoro","year":"2002","unstructured":"Tadokoro S, Tomiyama Y, Honda S, Kashiwagi H, Kosugi S, Shiraga M, Kiyoi T, Kurata Y, Matsuzawa Y: Missense mutations in the \u03b23 subunit have a different impact on the expression and function between \u03b1IIb\u03b23 and \u03b1v\u03b23. Blood. 2002, 99: 931-938. 10.1182\/blood.V99.3.931.","journal-title":"Blood"},{"key":"10_CR29","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1126\/science.2392682","volume":"249","author":"JC Loftus","year":"1990","unstructured":"Loftus JC, O'Toole TE, Plow EF, Glass A, Frelinger AL, Ginsberg MH: A \u03b23 integrin mutation abolishes ligand binding and alters divalent cation-dependent conformation. Science. 1990, 249: 915-918.","journal-title":"Science"},{"key":"10_CR30","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1172\/JCI115808","volume":"89","author":"F Lanza","year":"1992","unstructured":"Lanza F, Stierle A, Fournier D, Morales M, Andre G, Nurden AT, Cazenave JP: A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg->Trp mutation. J Clin Invest. 1992, 89: 1995-2004.","journal-title":"J Clin Invest"},{"key":"10_CR31","doi-asserted-by":"publisher","first-page":"10169","DOI":"10.1073\/pnas.89.21.10169","volume":"89","author":"YP Chen","year":"1992","unstructured":"Chen YP, Djaffar I, Pidard D, Steiner B, Cieutat AM, Caen JP, Rosa JP: Ser752->Pro mutation in the cytoplasmic domain of integrin \u03b23 subunit and defective activation of platelet integrin \u03b1IIb\u03b23 (glycoprotein IIb-IIIa) in a variant of Glanzmann's thrombasthenia. Proc Natl Acad Sci USA. 1992, 89: 10169-10173.","journal-title":"Proc Natl Acad Sci USA"},{"key":"10_CR32","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1172\/JCI119780","volume":"100","author":"R Wang","year":"1997","unstructured":"Wang R, Shattil SJ, Ambruso DR, Newman PJ: Truncation of the cytoplasmic domain of \u03b23 in a variant form of Glanzmann thrombasthenia abrogates signaling through the integrin \u03b1IIb\u03b23 complex. J Clin Invest. 1997, 100: 2393-2403.","journal-title":"J Clin Invest"},{"key":"10_CR33","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1182\/blood.V92.11.4178","volume":"92","author":"O Peyruchaud","year":"1998","unstructured":"Peyruchaud O, Nurden AT, Milet S, Macchi L, Pannochia A, Bray PF, Kieffer N, Bourre F: R to Q aminoacid substitution in the GFFKR sequence of the cytoplasmic domain of the integrin \u03b1IIb subunit in a patient with a Glanzmann's thrombasthenia-like syndrome. Blood. 1998, 92: 4178-4187.","journal-title":"Blood"},{"key":"10_CR34","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1182\/blood-2002-07-2144","volume":"101","author":"T Kiyoi","year":"2003","unstructured":"Kiyoi T, Tomiyama Y, Honda S, Tadokoro S, Arai M, Kashiwagi H, Kosugi S, Kato H, Kurata Y, Matsuzawa Y: A naturally occurring Tyr143His\u03b1IIb mutation abolishes \u03b1IIb\u03b23 function for soluble ligands but retains its ability for mediating cell adhesion and clot retraction: comparison with other mutations causing ligand binding defects. Blood. 2003, 101: 3485-3491. 10.1182\/blood-2002-07-2144.","journal-title":"Blood"},{"key":"10_CR35","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1182\/blood.V98.8.2432","volume":"98","author":"C Ruiz","year":"2001","unstructured":"Ruiz C, Liu CY, Sun QH, Sigaud-Fiks M, Fressinaud E, Muller JY, Nurden P, Nurden AT, Newman PJ, Valentin N: A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (\u03b1IIb\u03b23) integrin receptor locked in a high affinity state and a Glanzmann thrombasthenia-like phenotype. Blood. 2001, 98: 2432-2441. 10.1182\/blood.V98.8.2432.","journal-title":"Blood"},{"key":"10_CR36","doi-asserted-by":"publisher","first-page":"38628","DOI":"10.1074\/jbc.M105737200","volume":"276","author":"P Chen","year":"2001","unstructured":"Chen P, Melchior C, Brons NH, Schlegel N, Caen J, Kieffer N: Probing conformational changes in the I-domain and the cysteine-rich repeat of human \u03b23 integrins following disulfide bond disruption by cysteine mutations: identification of cysteine 598 involved in \u03b1IIb\u03b23 activation. J Biol Chem. 2001, 276: 38628-38635. 10.1074\/jbc.M105737200.","journal-title":"J Biol Chem"},{"key":"10_CR37","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1055\/s-0037-1613129","volume":"87","author":"G D'Andrea","year":"2002","unstructured":"D'Andrea G, Colaizzo D, Vecchione G, Grandone E, Di Minno G, Margaglione M: GLAnzmann's Thrombasthenia Italian Team (GLATIT): Glanzmann's thrombasthenia: Identification of 19 new mutations in 30 patients. Thromb Haemost. 2002, 87: 1034-1042.","journal-title":"Thromb Haemost"},{"key":"10_CR38","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/j.1538-7836.2005.01159.x","volume":"3","author":"S Nair","year":"2005","unstructured":"Nair S, Ghosh K, Shetty S, Mohanty D: Mutations in GPIIIa molecule as a cause for Glanzmann thrombasthenia in Indian patients. J Thromb Haemost. 2005, 3: 482-428. 10.1111\/j.1538-7836.2005.01159.x.","journal-title":"J Thromb Haemost"},{"key":"10_CR39","first-page":"987","volume-title":"\"Hemostasis and Thrombosis, Basic Principles and Clinical Practice\"","author":"AT Nurden","year":"2005","unstructured":"Nurden AT, George JN: Inherited abnormalities of the platelet membrane: Glanzmann thrombasthenia, Bernard-Soulier syndrome, and other disorders. \"Hemostasis and Thrombosis, Basic Principles and Clinical Practice\" VI edition. Edited by: RW Colman, VJ Marder, AW Clowes, JN George, SZ Goldhaber. Lippincott, Williams & Wilkins, Philadelphia; 2005:987-1010.","edition":"VI"},{"key":"10_CR40","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0268-960X(02)00030-9","volume":"16","author":"S Bellucci","year":"2002","unstructured":"Bellucci S, Caen J: Molecular basis of Glanzmann's thrombasthenia and current strategies in treatment. Blood Rev. 2002, 16: 193-202. 10.1016\/S0268-960X(02)00030-9.","journal-title":"Blood Rev"},{"key":"10_CR41","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1161\/01.ATV.19.12.2835","volume":"19","author":"AT Nurden","year":"1999","unstructured":"Nurden AT, Poujol C, Durrieu-Jais C, Nurden P: Platelet glycoprotein IIb\/IIIa inhibitors: Basic and clinical aspects. Arterioscler Thromb Vasc Biol. 1999, 19: 2835-2840.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10_CR42","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1161\/hc0902.104676","volume":"105","author":"O Shpilberg","year":"2002","unstructured":"Shpilberg O, Rabi I, Schiller K, Walden R, Harats D, Tyrrell KS, Coller B, Seligsohn U: Patients with Glanzmann thrombasthenia lacking platelet glycoprotein \u03b1IIb\u03b23 (GPIIb\/IIIa) and \u03b1v\u03b23 receptors are not protected from atherosclerosis. Circulation. 2002, 105: 1044-1048. 10.1161\/hc0902.104676.","journal-title":"Circulation"},{"key":"10_CR43","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1046\/j.1538-7836.2003.00041.x","volume":"1","author":"H Ten Cate","year":"2003","unstructured":"Ten Cate H, Brandjes DPM, Smits PHM, Van Mourik JA: The role of platelets in venous thrombosis: a patient with Glanzmann's thrombasthenia and a factor V Leiden mutation suffering from deep venous thrombosis. J Thromb Haemost. 2003, 1: 394-395. 10.1046\/j.1538-7836.2003.00041.x.","journal-title":"J Thromb Haemost"},{"key":"10_CR44","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1172\/JCI8905","volume":"105","author":"KP McHugh","year":"2000","unstructured":"McHugh KP, Hodivala-Dilke K, Zheng MH, Namba N, Lam J, Novack D, Feng X, Ross FP, Hynes RO, Teitelbaum SL: Mice lacking \u03b23 integrins are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest. 2000, 105: 433-440.","journal-title":"J Clin Invest"},{"key":"10_CR45","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1046\/j.1365-2141.2003.04530.x","volume":"122","author":"MA Horton","year":"2003","unstructured":"Horton MA, Massey HM, Rosenberg N, Nicholls B, Seligsohn U, Flanaghan AM: Upregulation of osteoclast \u03b12\u03b21 integrin compensates for lack of \u03b1v\u03b23 vitronectin receptor in Iraqi-Jewish-type Glanzmann thrombasthenia. Br J Haematol. 2003, 122: 950-957. 10.1046\/j.1365-2141.2003.04530.x.","journal-title":"Br J Haematol"},{"key":"10_CR46","doi-asserted-by":"publisher","first-page":"8643","DOI":"10.1158\/0008-5472.CAN-04-2760","volume":"64","author":"AR Reynolds","year":"2004","unstructured":"Reynolds AR, Reynolds LE, Nagel TE, Lively JC, Robinson SD, Hicklin DJ, Bodary SC, Hodivala-Dilke KM: Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in \u03b23-integrin-deficient mice. Cancer Res. 2004, 64: 8643-8650. 10.1158\/0008-5472.CAN-04-2760.","journal-title":"Cancer Res"},{"key":"10_CR47","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/ajh.20159","volume":"77","author":"G Toogeh","year":"2004","unstructured":"Toogeh G, Sharifian R, Lak M, Safaee R, Artoni A, Peyvandi F: Presentation and pattern of symptoms in 382 patients with Glanzmann thrombasthenia in Iran. Am J Hematol. 2004, 77: 198-199. 10.1002\/ajh.20159.","journal-title":"Am J Hematol"},{"key":"10_CR48","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/00001721-200206000-00011","volume":"13","author":"Y Buyukasik","year":"2002","unstructured":"Buyukasik Y, Karakus S, Goker H, Haznedaroglu IC, Ozatli D, Sayinalp N, Ozcebe OI, Dundar SV, Kirazli S: Rational use of the PFA-100 device for screening of platelet function disorders and von Willebrand disease. Blood Coag Fibrinolysis. 2002, 13: 349-353. 10.1097\/00001721-200206000-00011.","journal-title":"Blood Coag Fibrinolysis"},{"key":"10_CR49","first-page":"500","volume":"616","author":"H Peretz","year":"1991","unstructured":"Peretz H, Seligsohn U, Zwang E, Coller BS, Newman PJ: Detection of the Glanzmann's thrombasthenia mutations in Arab and Iraqi-Jewish patients by polymerase chain reaction and restriction analysis of blood and urine samples. Thromb Haemost. 1991, 616: 500-504.","journal-title":"Thromb Haemost"},{"key":"10_CR50","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1182\/blood.V86.3.977.977","volume":"86","author":"N Schlegel","year":"1986","unstructured":"Schlegel N, Gayet O, Morel-Kopp MC, Wyler B, Hurtaud-Roux MF, Kaplan C, McGregor J: The molecular genetic basis of Glanzmann's thrombasthenia in a gypsy population in France: Identification of a new mutation on the \u03b1IIb gene. Blood. 1986, 86: 977-982.","journal-title":"Blood"},{"key":"10_CR51","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/09537109876915","volume":"9","author":"J Ruan","year":"1998","unstructured":"Ruan J, Peyruchaud O, Nurden P, Cazes E, Combrie R, Bourre F, Nurden AT: Family screening for a Glanzmann's thrombasthenia mutation using PCR-SSCP. Platelets. 1998, 9: 129-136. 10.1080\/09537109876915.","journal-title":"Platelets"},{"key":"10_CR52","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/S0140-6736(85)92579-6","volume":"2","author":"U Seligsohn","year":"1985","unstructured":"Seligsohn U, Mibashan RS, Rodeck CH, Nicolaides KH, Millar DS, Coller BS: Prenatal diagnosis in Glanzmann's thrombasthenia. Lancet. 1985, 2: 1419-10.1016\/S0140-6736(85)92579-6.","journal-title":"Lancet"},{"key":"10_CR53","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1046\/j.1365-2141.1998.00798.x","volume":"102","author":"DL French","year":"1998","unstructured":"French DL, Coller BS, Usher S, Berkowitz R, Eng C, Seligsohn U, Peretz H: Prenatal diagnosis of Glanzmann thrombasthenia using the polymorphic markers BRCA1 and THRAI on chromosome 17. Br J Haematol. 1998, 102: 582-587. 10.1046\/j.1365-2141.1998.00798.x.","journal-title":"Br J Haematol"},{"key":"10_CR54","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.4049\/jimmunol.168.4.2035","volume":"168","author":"MJ Jacobin","year":"2002","unstructured":"Jacobin MJ, Laroche-Traineau J, Little M, Keller A, Peter K, Welschof M, Nurden A, Clofent-Sanchez G: Human IgG monoclonal anti-\u03b1IIb\u03b23-binding fragments derived from immunized donors using phage display. J Immunol. 2002, 168: 2035-2045.","journal-title":"J Immunol"},{"key":"10_CR55","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1046\/j.1365-2141.2002.03936.x","volume":"119","author":"I Martin","year":"2002","unstructured":"Martin I, Kriaa F, Proulle V, Guillet B, Kaplan C, D'Oiron R, Debre M, Fressinaud E, Laurian Y, Tchernia G, Charpentier B, Lambert T, Dreyfus M: Protein A Sepharose immunoadsorption can restore the efficacy of platelet concentrates in most patients with Glanzmann's thrombasthenia and anti-glycoprotein IIb-IIIa antibodies. Br J Haematol. 2002, 119: 991-997. 10.1046\/j.1365-2141.2002.03936.x.","journal-title":"Br J Haematol"},{"key":"10_CR56","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/j.1538-7836.2004.00767.x","volume":"2","author":"MC Poon","year":"2004","unstructured":"Poon MC, D'Oiron R, Von Depka M, Khair K, Negrier C, Karafoulidou A, Huth-Kuehne A, Morfini M: International Data Collection on Recombinant Factor VIIa and Congenital Platelet Disorders Study Group: Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey. J Thromb Haemost. 2004, 2: 1096-1103. 10.1111\/j.1538-7836.2004.00767.x.","journal-title":"J Thromb Haemost"},{"key":"10_CR57","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1538-7836.2005.01127.x","volume":"3","author":"S He","year":"2005","unstructured":"He S, Jacobsson Ekman G, Hedner U: The effect of platelets on fibrin gel structure formed in the presence of recombinant factor VIIa in hemophilia plasma and in plasma from a patient with Glanzmann thrombasthenia. J Thromb Haemost. 2005, 3: 272-279. 10.1111\/j.1538-7836.2005.01127.x.","journal-title":"J Thromb Haemost"},{"key":"10_CR58","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1046\/j.1365-2141.2003.04286.x","volume":"121","author":"AM Almeida","year":"2003","unstructured":"Almeida AM, Khair K, Hann I, Liesner RI: The use of recombinant factor VIIa in children with inherited platelet function disorders. Br J Haematol. 2003, 121: 477-481. 10.1046\/j.1365-2141.2003.04286.x.","journal-title":"Br J Haematol"},{"key":"10_CR59","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/j.1365-2141.1985.tb07358.x","volume":"59","author":"S Bellucci","year":"1985","unstructured":"Bellucci S, Devergie A, Gluckman E, Tobelem G, Lethielleux P, Benbunan M, Schaison G, Boiron M: Complete correction of Glanzmann's thrombasthenia by allogeneic bone-marrow transplantation. Br J Haematol. 1985, 59: 635-641.","journal-title":"Br J Haematol"},{"key":"10_CR60","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1182\/blood-2004-04-1257","volume":"104","author":"SJ Shattil","year":"2004","unstructured":"Shattil SJ, Newman PJ: Integrins: dynamic scaffolds for adhesion and signaling in platelets. Blood. 2004, 104: 1606-1615. 10.1182\/blood-2004-04-1257.","journal-title":"Blood"},{"key":"10_CR61","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1182\/blood-2004-01-0349","volume":"104","author":"TJ Kunicki","year":"2004","unstructured":"Kunicki TJ, Federici AB, Salomon DR, Koziol JA, Head SR, Mondala TS, Chismar JD, Baronciani L, Canciani MT, Peake IR: An association of candidate gene haplotypes and bleeding severity in von Willebrand disease (VWD) type I pedigrees. Blood. 2004, 104: 2359-2367. 10.1182\/blood-2004-01-0349.","journal-title":"Blood"},{"key":"10_CR62","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1046\/j.1538-7836.2003.00476.x","volume":"1","author":"DA Wilcox","year":"2003","unstructured":"Wilcox DA, White GC: Gene therapy for platelet disorders: studies with Glanzmann's thrombasthenia. J Thromb Haemost. 2003, 1: 2300-2311. 10.1046\/j.1538-7836.2003.00476.x.","journal-title":"J Thromb Haemost"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1172-1-10.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1750-1172-1-10\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1172-1-10.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T22:09:47Z","timestamp":1627250987000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/1750-1172-1-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,6]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["10"],"URL":"https:\/\/doi.org\/10.1186\/1750-1172-1-10","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,6]]},"article-number":"10"}}